Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DUTASTERIDE
- Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
- Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
- Phase II Dutasteride in Combination With CAB vs CAB in SDC
- Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
- Role of Dutasteride in Treatment of Chronic Prostatitis
- EAT-DUTA AndroCoV Trial
- Study of PCUR-101 in Combination With ADT in Patients With mCRPC
- Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients
- Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen
- Anti-Androgen Treatment for COVID-19
- 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
- Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy
- Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil
- Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia
- Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
- A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
- Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects
- Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects
- Safety and Pharmacokinetic Characteristics of DKF-313
- Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer
- Enzalutamide & Dutasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
- Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States
- A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy
- ITT-5 Mechanisms of Spermatogenesis in Man
- Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State
- Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia
- Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State
- Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
- This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study
- Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
- Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers
- Finasteride, Dutasteride and Insulin Action
- A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia
- JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
- Prospective Sexual Function Study for BPH Subjects
- Dutasteride Treatment for the Reduction of Heavy Drinking in Men
- Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
- Bioequivalence - Duodart Against Avodart & Omnic
- Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
- Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies
- Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects
- Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
- Response of Patients on Surveillance for Prostate Cancer to Dutasteride
- A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in
- Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.
- Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
- Drug Use Investigation for AVOLVE(BPH)
- STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling
- Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
- Economic Analyses of the REDUCE Trial
- Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use
- AVODART(Dutasteride) Post-marketing Surveillance(PMS)
- Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
- Dutasteride for the Reduction of Alcohol Use in Male Drinkers
- A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-
- Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
- ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
- Dutasteride in Treating Patients With Prostate Cancer
- AVODART® Alopecia Post-marketing Surveillance (PMS)
- Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer
- Metabolic Effects of Steroids in Obese Men
- Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
- Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS)
- ARI103094-Follow-Up Study for REDUCE Study Subjects
- Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
- Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
- Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
- Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
- Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
- Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia
- Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement
- Pharmacogenetics of Alcohol: Treatment Implications
- MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
- Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia
- A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
- Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker
- Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
- Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
- A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
- ARTS - AVODART After Radical Therapy For Prostate Cancer Study
- Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
- A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State
- Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
- The Role of 5-alpha Reductase in Mediating Testosterone Actions
- PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
- Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
- A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia
- A Clinical Trial Comparing Laser TURP With and Without Dutasteride.
- Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
- Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
- Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
- Oral Androgens in Man-4: (Short Title: Oral T-4)
- 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men
- Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer
- Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H)
- Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
- Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
- Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
- Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)
- Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
- Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP)
- Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
- TRADE-Testosterone Replacement and Dutasteride Effectiveness
- Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
- Testosterone and Its Metabolites in GID
- Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment
- Dutasteride to Treat Women With Menstrually Related Mood Disorders
- The Effect of 5-Alpha Reductase on Testosterone in Men
- Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Clinical trials list
click for details